Dietary flavonoids are associated with longitudinal treatment outcomes in neovascular age-related macular degeneration.
Harshil Dharamdasani DetaramGerald LiewJoshua R LewisNicola P BondonnoCatherine P BondonnoKim Van VuGeorge BurlutskyJonathan M HodgsonPaul MitchellBamini GopinathPublished in: European journal of nutrition (2021)
Higher intakes of dietary flavonoids, specifically flavonols and flavan-3-ols, could be associated with better long-term treatment outcomes in nAMD patients receiving anti-VEGF therapy. Confirmation of these associations in interventional studies could result in promising new therapeutic approaches to the treatment of nAMD.